Combined treatments for major depression

Area of Science:

• Psychiatry and Pharmacology
• Clinical Neuroscience

Background:

• Major depression is a chronic, debilitating disorder with significant morbidity and mortality.
• Current approved treatments primarily involve monotherapy with various antidepressant classes.
• There's a growing trend towards using augmentation and combination strategies.

Purpose of the Study:

• To review available data supporting augmentation and combination treatments for major depression.
• To evaluate the efficacy of using multiple pharmacologic agents concurrently or adjunctively.

Main Methods:

• Literature review of studies on antidepressant augmentation and combination therapies.
• Analysis of clinical trial data and meta-analyses.

Main Results:

• Data supports the use of augmentation (adding a non-antidepressant) and combination (using two antidepressants) strategies.
• These approaches aim to enhance or accelerate treatment response in major depression.

Conclusions:

• Augmentation and combination therapies represent important therapeutic options for major depression.
• Further research is needed to optimize these complex treatment regimens.